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Problems with the WHO guidelines for management of 
childhood pneumonia
Global child mortality has fallen substantially in the past 
25 years. Available data and modelled estimates indicate 
that pneumonia mortality has fallen to a greater 
extent.1 Although improved community development 
and immunisation have no doubt contributed to 
this decline, improved management of cases is also a 
major factor. For virtually all high-mortality settings, 
the WHO case management strategy implemented 
as a component of the Integrated Management of 
Childhood Illness (IMCI) algorithm has formed the 
basis for pneumonia management. The algorithm for 
pneumonia management had not changed for 24 years 
until 2013 when the key physical sign previously used 
to identify severe pneumonia cases (lower chest wall 
indrawing) was downgraded to become a sign of non-
severe pneumonia, to be managed with oral antibiotics 
at home.2
In The Lancet Global Health, Ambrose Agweyu and 
colleagues3 report a large, retrospective study of 
pneumonia admissions among 16 031 Kenyan children 
admitted to 14 Kenyan hospitals. At the time, Kenya 
was using both Haemophilus influenzae type b and 
pneumococcal conjugate vaccines. 832 fatal cases 
(5%) were reported. This case fatality rate might seem 
high, but it is probably typical for much of sub-Saharan 
Africa. Of the children who died, at least 322 (39%) 
would have been classified by WHO as having non-
severe pneumonia requiring home treatment by the 
2013 revision. These children actually did die despite 
inpatient treatment, but the fact that the WHO IMCI 
revision would have sent them home raises very 
serious questions. Review of the children who were 
likely misclassified as non-severe pneumonia (due to 
their fatal outcome) showed that risk of mortality is 
associated with malnutrition (frequently unrecognised) 
and pallor. The latter might indicate some diagnostic 
confusion between malaria and pneumonia, although 
Agweyu and colleagues state that this risk factor held 
even in the non-malarious areas. Clearly, recognition 
of severe malnutrition remains an important issue. 
Of great concern is the strong association between 
lower chest wall indrawing and mortality in this group. 
Specifically, children classified as having non-severe 
pneumonia by the new definition, who had indrawing 
(and were admitted to hospital) had a case fatality rate 
of 3·2% (95% CI 2·7–3·7). Under the pre-2013 system 
these children would have been classified as having 
severe pneumonia in need of hospital care; under the 
current system they would have been sent home.
This study is not the only one to identify lower chest 
wall indrawing as an important sign of potentially 
fatal pneumonia. In South Africa, chest wall indrawing 
was a strong indicator of a fatal outcome in both HIV-
positive and HIV-negative children with pneumonia.4 
However, lower chest wall indrawing is a confusing 
sign. Wheezing children will often demonstrate the 
sign with moderately severe illness due to the reduced 
lung compliance associated with wheezing, so in areas 
where asthma prevalence is increasing this has led to 
problems with over-referral of children not deemed to 
be severely ill.5 Indrawing is also a sign that can be very 
subtle, and is easy to overcall. Not surprisingly then, 
a prospective study of Pakistani children, presenting 
as outpatients with acute respiratory infections and 
indrawing, enrolled a large number of children, most 
with wheezing illness with extremely low mortality.6 In 
such a group, clinical failures will occur, but will usually 
be due to viral infections such as respiratory syncytial 
virus (RSV) that can typically produce symptoms for 
7–10 days. Management at home with amoxicillin and 
daily review can be expected to have a similar failure rate 
to inpatient management, as was found.
It is extraordinary then that the study by Hazir 
and colleagues,6 supported by a non-randomised 
multi-country study that enrolled only 873 of the 
6582 “severe pneumonia” cases screened,7 with a 
case fatality rate of zero, should be used as the basis 
to revise the WHO algorithm for identification of 
severe pneumonia.8 African countries with high 
pneumonia mortality are now in the process of 
introducing this revised IMCI strategy. The study by 
Agweyu and colleagues3 gives some indication of the 
potentially serious consequences of this policy change. 
It has been argued that the use of pulse oximetry at 
community level could identify the cases that are truly 
in need of hospital care. This could certainly improve 
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the identification of severe cases; what proportion of 
potentially fatal cases could be identified by oximetry is 
an important area of current field research.
The study by Agweyu and colleagues3 also highlights 
the fact that, with current hospital care, about 5% of 
children with pneumonia in many African hospitals will 
die. Some of these will have very severe disease and 
cannot be saved, but this is probably a small group. 
Some children could be saved by ventilation or use of 
the much simpler bubble continuous positive airways 
pressure approach,9 but sadly there is also likely to be 
a substantial number of deaths that could be avoided 
by paying attention to basic clinical care, including 
nutrition, careful management of intravenous fluids (or 
avoiding the use of intravenous fluids), prevention of 
hypothermia, and prevention of nosocomial infections.
An urgent need exists for the WHO/IMCI pneumonia 
case management strategy to be reviewed and probably 
revised. What the world needs is a safe and effective 
system for the management of childhood pneumonia, 
re-examining the importance of chest wall indrawing, 
improving recognition of malnutrition, and taking note 
of the important role of anaemia, especially in malarious 
settings. Pulse oximetry at the primary care level should 
be the future, and future technological developments 
might add respiratory rate and work of breathing to 
the parameters measured by oximetry. However, for 
the foreseeable future, especially in the most difficult 
settings, simple clinical signs will be the means of 
identifying the most severe cases, so it is essential that 
we get this right.
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